obsolete neuroectodermal tumor
MONDO:0002084
Research intelligence
Directly mapped studies only · unique clinical trialsCurrent registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.
Medications under investigation
Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.
MONDO disease family
Recruiting studies by city
Trial status
Trial phase
Study start year
Investigated drug interventions
Neuroectodermal neoplasm
A neuroectodermal neoplasm is a neoplasm or tumor of the neuroectoderm. They are most commonly tumors in the central or peripheral nervous system. Tumors exhibiting neuroectodermal differentiation are classified into two main groups: Group I tumors/neoplasms: neuroendocrine carcinomas. These show predominantly epithelial differentiation. They include pituitary adenoma and carcinoid tumor Group II tumors/neoplasms: nonepithelial neuroectodermal neoplasms. These are predominantly neural in origin. They include melanoma, olfactory neuroblastoma, and Ewing's sarcoma.
Background only. Canonical identity remains MONDO; clinical-trial relationships come from ClinicalTrials.gov.Drugs being studied
Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.